HK Stock MarketDetailed Quotes

SKB BIO (06990)

Watchlist
  • 490.200
  • -5.400-1.09%
15min DelayNot Open Sep 22 16:07 CST
117.17BMarket Cap673.35P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SKB BIO (06990) Income Statement

Cumulative·All
YOY yoy
Hide blank lines yoy
Currency: CNY
2026/H1
2025/FY
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/Q9
2021/FY
2021/Q9
Total Revenue
+2.93%978.34M
+6.46%2.06B
-31.27%950.45M
+25.48%1.93B
+32.17%1.38B
+91.62%1.54B
--1.05B
+2387.26%803.93M
+2266.02%623.99M
--32.32M
--26.37M
Operating Revenue
+2.93%978.34M
+6.46%2.06B
-31.27%950.45M
+25.48%1.93B
+32.17%1.38B
+91.62%1.54B
--1.05B
+2387.26%803.93M
+2266.02%623.99M
--32.32M
--26.37M
Cost of Revenue
+16.88%-241.44M
+12.17%-579.14M
+5.11%-290.46M
+15.60%-659.39M
+17.40%-306.10M
-182.24%-781.31M
---370.57M
-1248.74%-276.83M
-991.51%-182.76M
---20.53M
---16.74M
Cost of Goods Sold
+16.88%-241.44M
+12.17%-579.14M
+5.11%-290.46M
+15.60%-659.39M
+17.40%-306.10M
-182.24%-781.31M
---370.57M
-1248.74%-276.83M
-991.51%-182.76M
---20.53M
---16.74M
Gross Profit
+11.65%736.90M
+16.11%1.48B
-38.70%659.99M
+67.77%1.27B
+59.35%1.08B
+44.03%759.19M
--675.66M
+4368.13%527.11M
+4482.29%441.23M
--11.80M
--9.63M
Operating Expense
-43.34%-1.24B
-27.15%-1.97B
-13.83%-864.31M
-25.95%-1.55B
-30.97%-759.33M
-30.92%-1.23B
---579.77M
-14.26%-941.29M
+5.39%-577.22M
---823.84M
---610.11M
Selling Expenses
-118.30%-390.60M
-160.10%-475.25M
-334.80%-178.93M
-835.38%-182.72M
---41.15M
---19.53M
----
----
----
----
----
Administrative Expenses
-8.20%-79.90M
-9.44%-178.72M
-12.16%-73.84M
+10.21%-163.31M
+26.37%-65.84M
-90.84%-181.88M
---89.42M
+0.91%-95.30M
+17.88%-63.59M
---96.17M
---77.44M
Research and Development Expenses
-25.66%-768.43M
-9.41%-1.32B
+6.25%-611.54M
-16.99%-1.21B
-33.04%-652.34M
-21.87%-1.03B
---490.35M
-16.26%-845.98M
+3.58%-513.62M
---727.67M
---532.68M
Special Items of Operating Income
+2265.93%752.06M
+3.93%145.24M
-66.33%31.79M
+55.61%139.76M
+291.36%94.40M
+2156.07%89.81M
--24.12M
-112.54%-4.37M
-228.96%-28.09M
--34.84M
--21.78M
Operating Profit
+244.92%250.03M
-151.98%-349.62M
-141.90%-172.53M
+63.81%-138.75M
+243.11%411.76M
+8.40%-383.38M
--120.01M
+46.15%-418.55M
+71.65%-164.08M
---777.20M
---578.70M
Financing Cost
+31.27%-2.08M
-62.22%-6.16M
-20.54%-3.02M
+95.50%-3.80M
+96.82%-2.51M
+43.35%-84.31M
---78.73M
-32.17%-148.81M
-38.98%-110.43M
---112.59M
---79.46M
Pretax Profit
+241.24%247.96M
-149.59%-355.78M
-142.90%-175.56M
+69.52%-142.55M
+891.47%409.25M
+17.57%-467.69M
--41.28M
+36.24%-567.36M
+58.29%-274.51M
---889.80M
---658.16M
Tax
+361.00%140.05M
+78.92%-26.19M
+130.68%30.38M
-16.70%-124.22M
-36.76%-99.03M
-118.41%-106.44M
---72.41M
---48.74M
---46.72M
----
----
Net Profit
+367.27%388.01M
-43.19%-381.97M
-146.80%-145.18M
+53.54%-266.77M
+1096.55%310.23M
+6.81%-574.13M
---31.13M
+30.76%-616.10M
+51.19%-321.23M
---889.80M
---658.16M
Profit from Continuing Operations
+367.27%388.01M
-43.19%-381.97M
-146.80%-145.18M
+53.54%-266.77M
+1096.55%310.23M
+6.81%-574.13M
---31.13M
+30.76%-616.10M
+51.19%-321.23M
---889.80M
---658.16M
Net Income to Parent Company
+367.27%388.01M
-43.19%-381.97M
-146.80%-145.18M
+53.54%-266.77M
+1096.55%310.23M
+6.81%-574.13M
---31.13M
+30.76%-616.10M
+51.19%-321.23M
---889.80M
---658.16M
Net Income to Common Stockholders
+367.27%388.01M
-43.19%-381.97M
-146.80%-145.18M
+53.54%-266.77M
+1096.55%310.23M
+6.81%-574.13M
---31.13M
+30.76%-616.10M
+51.19%-321.23M
---889.80M
---658.16M
Basic EPS
+361.17%1.66
-38.33%-1.66
-145.18%-0.64
+57.75%-1.20
+929.41%1.41
+50.52%-2.84
---0.17
+35.51%-5.74
+55.70%-2.99
---8.90
---6.75
Diluted EPS
+361.07%1.66
-38.33%-1.66
-145.18%-0.64
+57.75%-1.20
+929.41%1.41
+50.52%-2.84
---0.17
+35.51%-5.74
+55.70%-2.99
---8.90
---6.75
Deadline
Jun 30, 2026
Dec 31, 2025
Jun 30, 2025
Dec 31, 2024
Jun 30, 2024
Dec 31, 2023
Jun 30, 2023
Dec 31, 2022
Sep 30, 2022
Dec 31, 2021
Sep 30, 2021
Accounting Standard
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified opinion
--
Unqualified opinion
--
Unqualified opinion
--
Unqualified opinion
--
Unqualified opinion
--
2026/H12025/FY2025/H12024/FY2024/H12023/FY2023/H12022/FY2022/Q92021/FY2021/Q9

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +13.92%
Sample Name
Sample Code
 +7.78%
Sample Name
Sample Code
 +0.34%
4
SINO OIL & GAS
00702
0.00%
5
CNOOC
00883
-2.07%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +27.04%
Sample Name
Sample Code
 +24.41%
Sample Name
Sample Code
 +20.35%
4
China Great Wall Technology Group
000066
+12.95%
5
Lotus Holdings
600186
+11.95%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -